メインコンテンツにスキップ
検索

後期臨床

登録

最新のリソース

注目コンテンツ

Upcoming late clinical webinars

ウェビナー

Explore Smarter, Faster PK/PD with Phoenix

2026年5月12日 – 10-11 AM ET/CET/JST
ウェビナー

Pharmacometrics Under Pressure

2026年5月15日 – 10:00 - 11:00am ET

Latest late clinical blogs

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

ISPOR International Annual Conference 2026

May 17 - 20, 2026 – Philadelphia, PA
展示会・学会

CDISC EU 2026

May 18 - 22, 2026 – Milan, Italy
展示会・学会

2026 SNMMI Annual Meeting

May 30 - 2026年6月2日 – Los Angeles, CA

All late clinical resources

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

Why CROs should use Pinnacle 21 Enterprise for late phase clinical data validation

Certara Products - Pinnacle 21, Blog

Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome

Cardiovascular, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation – PK/PD, Therapeutic Specialties, Publication

Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation – PK/PD, Therapeutic Specialties, Publication

Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation – PK/PD, Therapeutic Specialties, Publication

The one-trial era: what the FDA’s shift signals for the future of drug development

Certara Products - Simcyp, Certara Services, Press Coverage

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

Certara Products - Certara IQ, Modeling and Simulation, Modeling and Simulation - QSP, Publication

GxP Compliance in the Cloud: What IT Teams Need to Rethink

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Blog

Optimize Readiness for MHRA-NICE Aligned Pathway

Certara Services, Drug Development, Blog

Understanding LC/MS/MS

Certara Services, Blog, Knowledge Base

QSP at an Inflection Point: Scaling Impact

Certara Products - Certara IQ, Modeling and Simulation - QSP, Blog

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

Certara Products - Certara IQ, Certara Products - Simcyp, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Blog
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software